Embecta Corp (EMBC)
13.10
-0.04
(-0.27%)
USD |
NASDAQ |
May 28, 16:00
13.08
-0.02
(-0.11%)
After-Hours: 20:00
Embecta Market Cap: 755.19M for May 28, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 28, 2024 | 755.19M |
| May 24, 2024 | 757.21M |
| May 23, 2024 | 749.14M |
| May 22, 2024 | 782.58M |
| May 21, 2024 | 789.50M |
| May 20, 2024 | 803.35M |
| May 17, 2024 | 833.33M |
| May 16, 2024 | 818.92M |
| May 15, 2024 | 792.97M |
| May 14, 2024 | 841.98M |
| May 13, 2024 | 817.76M |
| May 10, 2024 | 821.22M |
| May 09, 2024 | 816.61M |
| May 08, 2024 | 592.27M |
| May 07, 2024 | 608.42M |
| May 06, 2024 | 599.19M |
| May 03, 2024 | 585.35M |
| May 02, 2024 | 589.97M |
| May 01, 2024 | 584.11M |
| April 30, 2024 | 584.11M |
| April 29, 2024 | 601.98M |
| April 26, 2024 | 594.49M |
| April 25, 2024 | 599.68M |
| April 24, 2024 | 627.93M |
| April 23, 2024 | 627.36M |
| Date | Value |
|---|---|
| April 22, 2024 | 618.13M |
| April 19, 2024 | 612.36M |
| April 18, 2024 | 596.80M |
| April 17, 2024 | 590.45M |
| April 16, 2024 | 596.80M |
| April 15, 2024 | 610.63M |
| April 12, 2024 | 591.03M |
| April 11, 2024 | 634.85M |
| April 10, 2024 | 657.34M |
| April 09, 2024 | 681.56M |
| April 08, 2024 | 700.01M |
| April 05, 2024 | 735.76M |
| April 04, 2024 | 736.91M |
| April 03, 2024 | 729.42M |
| April 02, 2024 | 733.45M |
| April 01, 2024 | 755.94M |
| March 28, 2024 | 764.07M |
| March 27, 2024 | 742.77M |
| March 26, 2024 | 711.10M |
| March 25, 2024 | 721.46M |
| March 22, 2024 | 714.55M |
| March 21, 2024 | 747.95M |
| March 20, 2024 | 742.19M |
| March 19, 2024 | 739.89M |
| March 18, 2024 | 766.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
584.11M
Minimum
Apr 30 2024
2.679B
Maximum
Mar 22 2022
1.363B
Average
1.485B
Median
Dec 29 2022
Market Cap Benchmarks
| AIM ImmunoTech Inc | 17.95M |
| Perspective Therapeutics Inc | 971.30M |
| Protalix BioTherapeutics Inc | 85.05M |
| Electromed Inc | 122.65M |
| Armata Pharmaceuticals Inc | 95.09M |
Market Cap Related Metrics
| PE Ratio | 10.82 |
| PS Ratio | 0.6675 |
| Price to Free Cash Flow | 80.42 |
| Price | 13.10 |
| Earnings Yield | 9.24% |
| Operating PE Ratio | 4.601 |
| Normalized PE Ratio | 10.82 |